XPO1 and chronic myelogenous leukemia, BCR-ABL1 positive: Treatment of CML with KPT-330 caused a remarkable reduction in the amount of CRM1 and showed a significant nuclear accumulation of CRM1 cargo proteins, such as BCR-ABL and P27.